Found: 29
Select item for more details and to access through your institution.
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2179, doi. 10.1111/dom.14148
- By:
- Publication type:
- Article
Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1976, doi. 10.1111/dom.14145
- By:
- Publication type:
- Article
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m².
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2151, doi. 10.1111/dom.14144
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 11.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1, doi. 10.1111/dom.14227
- By:
- Publication type:
- Article
A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2004, doi. 10.1111/dom.14152
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 11.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1, doi. 10.1111/dom.14229
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1959, doi. 10.1111/dom.13722
- Publication type:
- Article
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2193, doi. 10.1111/dom.14140
- By:
- Publication type:
- Article
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143
- By:
- Publication type:
- Article
Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: A randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2120, doi. 10.1111/dom.14131
- By:
- Publication type:
- Article
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2161, doi. 10.1111/dom.14146
- By:
- Publication type:
- Article
Trial of restarting and tolerating metformin (TreatMet).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2189, doi. 10.1111/dom.14137
- By:
- Publication type:
- Article
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2170, doi. 10.1111/dom.14136
- By:
- Publication type:
- Article
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2141, doi. 10.1111/dom.14135
- By:
- Publication type:
- Article
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2133, doi. 10.1111/dom.14133
- By:
- Publication type:
- Article
Safety concerns of sodium-glucose co-transporter-2 inhibitors in type 1 diabetes: A real-world study from the perspective of the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2204, doi. 10.1111/dom.14138
- By:
- Publication type:
- Article
γ-aminobutyric acid stimulates β-cell proliferation through the mTORC1/p70S6K pathway, an effect amplified by Ly49, a novel γ-aminobutyric acid type A receptor positive allosteric modulator.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2021, doi. 10.1111/dom.14118
- By:
- Publication type:
- Article
Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the Canadian LMC diabetes registry (SPARE study).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2013, doi. 10.1111/dom.14117
- By:
- Publication type:
- Article
Features of oral glucose tolerance tests in patients after Roux-en-Y gastric bypass with and without hypoglycaemia symptoms in daily life: It's all about speed.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2107, doi. 10.1111/dom.14130
- By:
- Publication type:
- Article
Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2097, doi. 10.1111/dom.14129
- By:
- Publication type:
- Article
Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1961, doi. 10.1111/dom.14128
- By:
- Publication type:
- Article
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2089, doi. 10.1111/dom.14127
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2077, doi. 10.1111/dom.14126
- By:
- Publication type:
- Article
The effect of referral to an open-group behavioural weightmanagement programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: Secondary analysis of the WRAP trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2069, doi. 10.1111/dom.14123
- By:
- Publication type:
- Article
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2055, doi. 10.1111/dom.14122
- By:
- Publication type:
- Article
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2045, doi. 10.1111/dom.14121
- By:
- Publication type:
- Article
The effect of mirabegron on energy expenditure and brown adipose tissue in healthy lean South Asian and Europid men.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2032, doi. 10.1111/dom.14120
- By:
- Publication type:
- Article
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1995, doi. 10.1111/dom.14116
- By:
- Publication type:
- Article
Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte ATP homeostasis during substrate challenge.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1985, doi. 10.1111/dom.14111
- By:
- Publication type:
- Article